Fiasp injection Penfill, by Novo Nordisk Pharma, is a fast-acting insulin containing Insulin aspart (recombinant) for managing blood sugar levels in adults and children with diabetes mellitus. It is administered subcutaneously, has a YJ code of 2492415A6022, and a standard of 300 units per tube.
Fiasp injection Penfill
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).